NICE's initial guidance on Breyanzi concluded it was not a cost-effective option for patients, but the agency said this ...
Genmab (GMAB) announced that the Japan Ministry of Health, Labour and Welfare has approved EPKINLY or epcoritamab, for the treatment of ...
Yescarta (axicabtagene ciloleucel) has been approved as a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...
She herself had what’s known as stage 4 primary mediastinal non-Hodgkin’s large B-cell lymphoma. Her father Michael LoPorto, who died in 2022, was a well-known figure in the Capital Region ...
Dr. Axel Heidenreich presented the final results of the COTRIMS (Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma) trial. Clinical stage (CS) IIA/B seminoma accounts for only 10 ...
Bristol Myers' Opdivo improved overall survival in resectable NSCLC, per final Phase 3 data. The study confirms its benefit when combined with chemotherapy.
The addition of epcoritamab-bysp to standard chemotherapy significantly improved response and survival for patients with ...
Combination Targeted Treatment Produces Lasting Remissions in People With Resistant Aggressive B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy treatment regimen ...
Bristol Myers Squibb has bolstered its case for Opdivo to be used as a pre-operative treatment for non-small cell lung cancer ...
RAPID developments in thoracic surgery and increased use of mass roentgen surveys during the past decade have revealed a greater incidence of mediastinal ... along the primary or secondary bronchi ...
Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results